Archive for category: In The News

TFND is proud to announce our Video Essay Scholarship Contest has returned! The contest is open to all North Dakota high school seniors with a chance to win a $1,000 scholarship for college! For more information, please read the rules and regulations in our 2022 Video Essay Scholarship Press Packet.

If you use e-cigarettes and test positive for COVID-19, you’re more likely to develop symptoms than people who don’t vape. Mayo Clinic researchers studied the frequency of common COVID symptoms experienced by vapors and compared them to those of people who didn’t vape. To read the full story, click here.

Portland, Maine is mulling a ban on flavored tobacco products. These products are overwhelmingly marketed for and used by kids. To read the full report, click here.

North Dakota State University’s Kelly Buettner-Schmidt has also done multiple studies proving the contents of e-liquid containers don’t match the labels. Below is an excerpt to a summary of the piece:

“In December 2021, the North Dakota State University Tobacco Control and Prevention Research Team published an article1 in the journal, The Nurse Practitioner. I am happy to provide a description of our article for this newsletter. While this article was written for nurse practitioners (NPs), it pertains to all primary care providers, including physicians, physician assistants, nurse practitioners, pharmacists, and others. The majority of the below content is directly from that article. The article is available under the Creative Commons CC-BY-NCND license and permits non-commercial use of the work as published, without adaptation or alteration provided the work is fully attributed. I encourage you to read the full article directly as it is freely available to read, print, and use in your work from this link: https://journals.lww.com/tnpj/Fulltext/2021/12000/E_cigarettes_for_tobacco_cessation__Not_th e.2.aspx

In the article, we describe how primary care NPs frequently encounter patients who use ENDS, sometimes for tobacco cessation (cessation). We discuss how clinician involvement in tobacco cessation increases the likelihood of patients successfully quitting tobacco2 and that ENDS are not recommended for cessation because of health risks, lack of Food and Drug Administration (FDA) approval, and other reasons. We share that NPs can positively impact patients’ cessation efforts without using ENDS, and that many resources are available to aid them in this process.

The basics of nicotine addiction are described and that when ENDS were first introduced into the United States, some speculated that ENDS could be effectively used for cessation. However, more than half of the people who start using ENDS for cessation simply transfer their nicotine dependence to ENDS,2 often becoming dual users.3 We share the great concern that ENDS use among adolescents is associated with increased initiation of cigarette smoking and increased frequency and intensity of both regular cigarette and e-cigarette usage, 4 and that the use of ENDS products among adolescents leads to increased dependence upon nicotine products.3 We describe that after years of market availability, three separate clinical practice 2 guidelines (CPGs) recommend against the use of ENDs for tobacco cessation because of quality control concerns, insufficient data to demonstrate that the benefits outweighs the risks, and the availability of effective cessation tools. In the article, we provide details on why ENDS products are not an effective, safe, or approved means of cessation for either adults or adolescents.”

 

To read a summary of her latest piece, including a link to the full article, Ecig Not the Solution NPJ.